Company news
Spectral Medical Inc (TSX:EDT) news
Spectral Medical Inc news releases on 6ix. Latest, Aug 3, 2011: Spectral Diagnostics issues corporate update
Press releases — page 3
Spectral Diagnostics issues corporate update
August 3, 2011
SPECTRAL DIAGNOSTICS TO PRESENT AT BIOFINANCE 2011
May 19, 2011
SPECTRAL ANNOUNCES FIRST QUARTER RESULTS
May 12, 2011
SPECTRAL ACHIEVES IMPORTANT MILESTONE IN ITS PIVOTAL U.S. CLINICAL TRIAL FOR SEPSIS
May 5, 2011
SPECTRAL DIAGNOSTICS REFILES THIRD QUARTER UNAUDITED INTERIM FINANCIAL STATEMENTS
April 11, 2011
SPECTRAL DIAGNOSTICS ANNOUNCES FOURTH QUARTER AND 2010 YEAR END RESULTS
March 10, 2011
SPECTRAL DIAGNOSTICS COMPLETES CONVERSION OF PROMISSORY NOTES
December 31, 2010
SPECTRAL OBTAINS EXCLUSIVE CANADIAN DISTRIBUTION RIGHTS FOR TORAYMYXIN?
November 22, 2010
SPECTRAL ANNOUNCES THIRD QUARTER 2010 RESULTS
November 15, 2010
SPECTRAL INITIATES U.S. PIVOTAL TRIAL OF TORAYMYXIN¿ IN SEPTIC SHOCK
October 19, 2010
SPECTRAL TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 13
September 13, 2010
Spectral announces second quarter 2010 results
August 12, 2010
Spectral receives McMaster Industry Partner of the Year Award for aptamer discovery research
June 23, 2010
Spectral announces first quarter financial results
May 14, 2010
Spectral announces presentations at the 8th Annual World Congress on Trauma, Shock, Inflammation and Sepsis focusing on the role of endotoxin
March 12, 2010
Spectral announces 2009 financial results
March 11, 2010
Spectral appoints two new board members
March 10, 2010
Spectral closes $19.5 million private placement financing
March 3, 2010
Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM)
March 2, 2010
Spectral shareholders approve $19.5 million private placement financing
February 26, 2010
Spectral increases private placement financing to $19.5 million
February 3, 2010
Spectral announces third quarter 2009 results
November 12, 2009
Spectral appoints new board member
August 13, 2009
Spectral announces second quarter 2009 results
August 13, 2009
Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial
June 18, 2009
Spectral announces first quarter 2009 results
May 14, 2009
Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin
March 25, 2009
Spectral announces 2008 financial results
March 12, 2009
Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
March 9, 2009
Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan
February 23, 2009
Spectral announces third quarter 2008 results
November 12, 2008
Spectral to bring anti-sepsis therapy to the U.S. market
September 23, 2008
Spectral announces second quarter 2008 results
August 13, 2008
Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
July 10, 2008
Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
June 26, 2008
Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
June 2, 2008
Spectral announces first quarter 2008 results
May 14, 2008
Spectral and Toray expand collaboration to include new geographic territories
May 5, 2008
Spectral's EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
April 9, 2008
Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
March 18, 2008
Spectral announces 2007 financial results
March 7, 2008
Spectral appoints Anthony Bihl to Board of Directors
March 6, 2008
Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
February 28, 2008
Spectral announces license agreement with Bio-Rad Pasteur S.A.
November 19, 2007
Spectral announces third quarter fiscal 2007 financial results
November 8, 2007
Spectral and Toray expand distribution of EAA(TM) diagnostic in Japan
November 6, 2007
Spectral Co-hosts Endotoxemia Scientific Session at SEPSIS 2007
September 27, 2007
Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
September 20, 2007
Spectral reports second quarter results
August 9, 2007
Spectral launches U.S. distribution of its Rapid West Nile Test
July 4, 2007